Chabiotech Co.,Ltd. (KOSDAQ:085660)
South Korea · Delayed Price · Currency is KRW 14,670
+60 (0.41%)
At close: Dec 30, 2025
Chabiotech Market Cap
Chabiotech has a market cap or net worth of 1.11 trillion as of December 30, 2025. Its market cap has increased by 32.17% in one year.
Market Cap
1.11T
Enterprise Value
2.04T
Revenue
1.20T
Ranking
n/a
PE Ratio
n/a
Stock Price
14,670.00
Market Cap Chart
Since February 23, 2009, Chabiotech's market cap has increased from 334.13B to 1.11T, an increase of 232.12%. That is a compound annual growth rate of 7.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 29, 2025 | 1.11T | 73.00% |
| Dec 30, 2024 | 641.46B | -41.85% |
| Dec 28, 2023 | 1.10T | 50.82% |
| Dec 29, 2022 | 731.49B | -34.83% |
| Dec 30, 2021 | 1.12T | 6.53% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 78.32T |
| Celltrion | 39.38T |
| ALTEOGEN | 23.48T |
| ABL Bio | 10.97T |
| SK Biopharmaceuticals | 9.80T |
| Yuhan | 8.41T |
| LigaChem Biosciences | 6.55T |
| HLB Co., Ltd. | 6.06T |